“…The differentiation continued using maintenance media (composition is the same as the induction cocktail, but without IBMX) until day 14. During the complete course of differentiation (14 days), cells were incubated in the absence or presence of either vehicle control (dimethyl sulfoxide, DMSO, Sigma) or therapeutic and supra-therapeutic concentrations of SGAs: ARI 1, 2, and 10 μM (AC457990010; ACROS Organics, ThermoFisher); ARI's active metabolite dehydroaripiprazole (DARI) 0.4 and 4 μM (1042690; US Pharmacopeial Convention, Rockville, USA); and OLA 0.2 and 2 μM, (GP8311, Glentham Life Sciences, Corsham, UK) as shown previously in the treatment of human adipose tissue ex vivo (Sarsenbayeva et al, 2019(Sarsenbayeva et al, , 2021. The drugs were present in the induction and maintenance differentiation medium.…”